Sign in

CIK 0001228627

  • Non-accelerated filer
  • Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113516358
Phone
+1 984-884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,211,769
in 7 filings, $50K under 10b5-1 plans

Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 46 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-02-28 Suzdak Peter David Chief Executive Officer Exercise or conversion +6,250 22,250
2018-02-28 Suzdak Peter David Chief Executive Officer Exercise or conversion · Restricted Stock Units +6,250 18,750
2018-01-26 Suzdak Peter David Chief Executive Officer Grant or award · Stock Option (right to buy) +112,271 112,271
2018-01-26 Nolan Lisa Chief Business Officer Grant or award · Stock Option (right to buy) +42,101 42,101
2018-01-26 Benaim Ely Chief Medical Officer Grant or award · Stock Option (right to buy) +45,443 45,443
2018-01-02 Swirsky Douglas J President and CFO Grant or award · Stock Option (right to buy) +250,000 250,000
2017-08-16 Suzdak Peter David Chief Executive Officer Grant or award +10,000 $1.99 $20K 16,000
2017-04-11 CARTHY MARK Director Grant or award · Stock Option (right to buy) +110,000 110,000
2017-04-11 Cheong Kwang Soo Director Grant or award · Stock Option (right to buy) +110,000 110,000
2017-04-11 Rodgers Richard J Director Grant or award · Stock Option (right to buy) +110,000 110,000
2017-04-11 Brandt Peter C. Director Grant or award · Stock Option (right to buy) +110,000 110,000
2017-04-11 Beever Charles Director Grant or award · Stock Option (right to buy) +110,000 110,000
2017-04-10 Ahn Chang Ho Director Exercise or conversion +250,000 $0.31 $78K 6,260,000
2017-04-10 Ahn Chang Ho Director Sale −250,000 $0.70 $175K 6,010,000
2017-04-10 Ahn Chang Ho Director Exercise or conversion · Stock Option (right to purchase) −250,000 0
2017-01-20 Jeong Tae Heum Chief Financial Officer Grant or award · Stock Option (right to buy) +300,000 300,000
2017-01-20 Jeong Tae Heum Chief Financial Officer Grant or award · Restricted Stock Units +63,000 63,000
2017-01-20 Suzdak Peter David Chief Executive Officer Grant or award · Stock Option (right to buy) +1,175,000 1,175,000
2017-01-20 Suzdak Peter David Chief Executive Officer Grant or award · Restricted Stock Units +250,000 250,000
2017-01-20 Benaim Ely Chief Medical Officer Grant or award · Stock Option (right to buy) +450,000 450,000

Page 16 of 22 · 437 trades